Abstract

Background

Several articles have proposed reference values in healthy paediatric subjects, but none of them has evaluated a large population of healthy trained adolescents.

Design

The study purpose was to establish normal echocardiographic measurements of left heart (aortic root, left atrium and left ventricular dimensions and mass) in relation to age, weight, height, body mass index, body surface area and training hours in this specific population.

Methods

We retrospectively evaluated 2151 consecutive, healthy, peri-pubertal athletes (100% male, mean age 12.4 ± 1.4 years, range 8–18) referred to a single centre for pre-participation screening. All participants were young soccer athletes who trained for a mean of 7.2 ± 1.1 h per week.

Results

Left ventricular internal diameters, wall thickness, left ventricular mass, aortic root and left atrium diameters were significantly correlated to age, body surface area, height and weight (p < 0.01). Age, height, weight and body surface area were found associated with chamber size, while body mass index and training hours were not. Inclusion of both age and body size parameters in the statistical models resulted in improved overall explained variance for diameters and left ventricular mass.

Conclusion

Equations, mean values and percentile charts for the different age groups may be useful as reference data in efficiently assessing left ventricular parameters in young athletes.

Introduction

The physiological, morphologic and functional changes induced in the heart as a result of regular physical training and sport activities are less evident in teens and young junior athletes, as they are less physically mature and exposed to fewer years of intense training1 compared with adults. The goal of the pre-participation screening (PPS) is to differentiate between physiological adaptive changes and an initial pathology. Transthoracic echocardiography has become the standard non-invasive imaging modality in screening only for presence of clinically suspicious anomalies, uncommon and training-unrelated electrocardiogram (ECG) abnormalities and on discovery of a positive family history.2,3 The correct interpretation of data strongly relies on the available echocardiographic reference values, but paradoxically the latter are derived from adult series or refer to small paediatric populations, with high variability in the methodology. The lack of robust standardized nomograms based on a large set of healthy young athletes may hamper the accuracy of estimating the presence of cardiac abnormalities, or introduce a bias in the PPS decision-making process.4 Moreover, standardized methodologies in performing normalization for Z-score calculation, especially in the presence of heteroscedasticity and non-linear relationships, are lacking.5 Recently, Z-scores have been published exclusively for normalized pulse wave Doppler and tissue Doppler imaging in paediatric echocardiography.6 We aimed to provide echocardiographic left heart reference values and Z-score equations to better define the physiologic limits of left heart remodelling in a large and homogenous population of trained peri-pubertal athletes and compare our data with the existing literature that evaluated untrained subjects.

Methods

Study design

This retrospective study includes all the consecutive junior soccer players (8–18 years old, trained for at least nine months, 100% male, all Caucasian) evaluated for PPS at the Sports Medicine Institute of Rome between January 2008 and March 2009. The soccer players were engaged in training 7.3 ± 1.2 h per week, including warm-up, technical/tactical skills, aerobic training reaching at least 75% of the maximal heart rate, strength training and cool down. All athletes underwent a conventional Italian PPS, which by law must be performed every 12 months in the case of competitive athletes, and includes ECG, medical history and physical examination. In addition, all athletes underwent a complete echocardiographic study, as previously described in two papers evaluating the overall study population.7,8 All athletes with a normal echocardiographic evaluation were included. Exclusion criteria were: the presence of any abnormal echocardiographic findings, including any form of cardiomyopathy, bicuspid aortic valve, mitral valve prolapse, inter-atrial septal defect, and even minor defects such as patent foramen ovale. We also excluded children with a body mass index (BMI) for age >2 (obese subjects, based on World Health Organization charts) because the presence of a high level of fat mass in adolescents can introduce a bias.9 This investigation complied with the international guidelines related to patient confidentiality and research ethics.10 Parents signed a written informed consent at the moment of PPS and the Institutional Review Board approved the study.

Echocardiography

All consecutive subjects underwent a conventional two-dimensional (2D) Doppler transthoracic echocardiography, performed with a commercially available machine (Siemens Acuson X300) equipped with a 5.1 and an 8.4 MHz probe. M-mode, 2D echocardiographic data, as well as pulsed, continuous and colour Doppler flow mapping were digitally recorded for off-line analysis and reviewed by an experienced cardiologist with a strong expertise in sport cardiology and echocardiography. The parameters of left ventricular (LV) geometry were measured off-line in 2D, including interventricular septum (IVS), posterior wall thickness (LVPW) and LV end-diastolic (LVEDD), end-systolic (LVESD) diameters and linear fractional shortening. A combination of long-axis and short-axis was used to ascertain that the short-axis or minor-axis measurement was perpendicular to and crossed the mid-points of the ventricular septum and posterior wall and that the LV short-axis geometry was circular throughout the cardiac cycle.11 LV mass (LVM) was calculated using the corrected American Society of Echocardiography convention11 proposed by Devereux: LV mass (LVM, g) = 0.8 × 1.04 × ((LVEDD + LVPW + IVS)3− LVEDD3) + 0.6. Fractional shortening was calculated with the assumption of a cylindrical shaped LV, using the conventional formula [(LVEDD – LVESD)/LVEDD]*100. Fractional shortening is related to the effect of age. For a given level of end-systolic stress, fractional shortening decreased by 0.26%/year in children and adolescents,12 so we decided to test this variable instead of LV ejection fraction, which does not show the same relationship with age.

Height and weight were measured to the nearest 0.1 cm and 0.1 kg using a wall-mounted stadiometer and a digital scale, respectively. BMI was calculated as weight (kg) divided by height2 (m2). Body surface area (BSA) was calculated applying the Haycock formula13 as it is recognized as the most appropriate for describing the growth of cardiovascular structures.14

Statistical analysis

Clinical, demographic, and echocardiographic data are presented as mean ± SD for continuous variables and as absolute numbers and percentages for categorical variables. The degree of association between left heart measurements and age, echocardiographic and anthropometric data was quantified by means of Pearson’s correlation coefficient (r2). Allometric normative equations for diameters were obtained using linear regression, univariate or multiple using stepwise forward approach, after log-transforming dependent (diameters) and independent (age, BSA, BMI, height, weight and training) variables. A set of nomograms displaying the upper limits of normal for each of the left heart measurements was obtained by adding two SDs to the mean predicted diameter. Standardized Z-score equations were defined based on the regression coefficients and the mean square error.

For the sake of clarity, results and graphs referring to age have been presented coupling consecutive years, although age has been considered as a continuous variable in all the performed statistical analyses.

Variables measured in different age groups were compared using analysis of variance test with post-hoc Bonferroni correction for multiple comparisons.

To assess the reproducibility of the echocardiographic measurements, image analysis was repeated in 20 randomly selected study subjects by an experienced cardiologist (author EC) and then repeated two weeks after. Inter- and intra-observer variability was expressed as the coefficient of variation, defined as the absolute difference of the corresponding pair of repeated measurements in percentage of their mean in each subject and then averaged over the entire group.

p-values < 0.05 were considered significant. Statistical analysis was performed using SPSS version 17.0 (SPSS, Chicago, IL, USA).

Results

Anthropometric and echocardiographic data

Among the 2261 subjects initially screened in a previous study,8 2151 (95%) subjects were included in the study. The remaining 110 subjects were excluded from the study because of any abnormal echocardiographic findings, BMI for age >2 or incomplete study. Table 1 presents the demographic and anthropometric data for participants included in the final analysis based on age distribution. In Table 2, the left heart echocardiographic parameters included are presented, based on age range. The distribution of the same data is depicted in Figure 1, and suggests a positive relation between age and LVEDD, LVESD, LVM, aortic root (AoR) and left atrial (LA) diameter. Conversely, only a weak association could be qualitatively assessed between age and IVS, LVPW or fractional shortening.

Table 1.

Demographic and anthropometric measurements.

Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
HR, beats/min68.8 ± 12.881.2 ± 13.2[2,3,4,5,6]74.2 ± 12.4[3,4,5,6]70.4 ± 11.3[4,5,6]66.0 ± 11.3[5,6]62.4 ± 11.1[6]59.3 ± 10.0
SBP, mmHg110.0 ± 10.6103.7 ± 12.0[3,4,5,6]105.2 ± 10.7[3,4,5,6]108.1 ± 9.4[4,5,6]112.6 ± 9.2[5,6]114.9 ± 9.4117.0 ± 7.9
DBP, mmHg69.2 ± 7.365.6 ± 8.3[3,4,5,6]66.7 ± 7.2[3,4,5,6]67.9 ± 6.6[4,5,6]70.6 ± 6.8671.8 ± 6.973.3 ± 5.9
Weight, kg49.8 ± 14.831.2 ± 6.6[2,3,4,5,6]37.1 ± 8.2[3,4,5,6]44.6 ± 9.5[4,5,6]55.1 ± 10.5[5,6]65.3 ± 9.6[6]69.6 ± 8.9
Height, cm156.9 ± 15.9132.8 ± 5.8 [2,3,4,5,6]140.9 ± 7.0[3,4,5,6]151.6 ± 8.4[4,5,6]165.2 ± 8.9[5,6]173.9 ± 7.5[6]177.9 ± 6.1
BMI, kg/m219.7 ± 3.117.6 ± 3.0[2,3,4,5,6]18.5 ± 3.1[3,4,5,6]19.3 ± 3.0[4,5,6]20.1 ± 2.6[5,6]21.5 ± 2.522.0 ± 2.3
BSA, (m2)1.47 ± 0.291.07 ± 0.12[2,3,4,5,6]1.20 ± 0.14[3,4,5,6]1.37 ± 0.17[4,5,6]1.60 ± 0.18[5,6]1.78 ± 0.15[6]1.86 ± 0.13
Training, h/week7.3 ± 1.26.3 ± 0.8[3,4,5,6]6.3 ± 0.7[3,4,5,6]7.0 ± 1.2[4,5,6]8.1 ± 0.78.1 ± 0.88.2 ± 0.9
Duration of training, months29.7 ± 12.712.3 ± 1.6[2,3,4,5,6]14.5 ± 8.6[3,4,5,6]28.4 ± 12.2[4,5,6]32.7 ± 16.1[5,6]41.4 ± 6.0[6]64.3 ± 5.7
Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
HR, beats/min68.8 ± 12.881.2 ± 13.2[2,3,4,5,6]74.2 ± 12.4[3,4,5,6]70.4 ± 11.3[4,5,6]66.0 ± 11.3[5,6]62.4 ± 11.1[6]59.3 ± 10.0
SBP, mmHg110.0 ± 10.6103.7 ± 12.0[3,4,5,6]105.2 ± 10.7[3,4,5,6]108.1 ± 9.4[4,5,6]112.6 ± 9.2[5,6]114.9 ± 9.4117.0 ± 7.9
DBP, mmHg69.2 ± 7.365.6 ± 8.3[3,4,5,6]66.7 ± 7.2[3,4,5,6]67.9 ± 6.6[4,5,6]70.6 ± 6.8671.8 ± 6.973.3 ± 5.9
Weight, kg49.8 ± 14.831.2 ± 6.6[2,3,4,5,6]37.1 ± 8.2[3,4,5,6]44.6 ± 9.5[4,5,6]55.1 ± 10.5[5,6]65.3 ± 9.6[6]69.6 ± 8.9
Height, cm156.9 ± 15.9132.8 ± 5.8 [2,3,4,5,6]140.9 ± 7.0[3,4,5,6]151.6 ± 8.4[4,5,6]165.2 ± 8.9[5,6]173.9 ± 7.5[6]177.9 ± 6.1
BMI, kg/m219.7 ± 3.117.6 ± 3.0[2,3,4,5,6]18.5 ± 3.1[3,4,5,6]19.3 ± 3.0[4,5,6]20.1 ± 2.6[5,6]21.5 ± 2.522.0 ± 2.3
BSA, (m2)1.47 ± 0.291.07 ± 0.12[2,3,4,5,6]1.20 ± 0.14[3,4,5,6]1.37 ± 0.17[4,5,6]1.60 ± 0.18[5,6]1.78 ± 0.15[6]1.86 ± 0.13
Training, h/week7.3 ± 1.26.3 ± 0.8[3,4,5,6]6.3 ± 0.7[3,4,5,6]7.0 ± 1.2[4,5,6]8.1 ± 0.78.1 ± 0.88.2 ± 0.9
Duration of training, months29.7 ± 12.712.3 ± 1.6[2,3,4,5,6]14.5 ± 8.6[3,4,5,6]28.4 ± 12.2[4,5,6]32.7 ± 16.1[5,6]41.4 ± 6.0[6]64.3 ± 5.7

Data expressed as mean ± SD or as absolute count (% of total).

p < 0.05 current group versus Group J, pairwise comparisons with Bonferroni adjustment for multiple comparisons.

HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; BSA: body surface area.

Table 1.

Demographic and anthropometric measurements.

Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
HR, beats/min68.8 ± 12.881.2 ± 13.2[2,3,4,5,6]74.2 ± 12.4[3,4,5,6]70.4 ± 11.3[4,5,6]66.0 ± 11.3[5,6]62.4 ± 11.1[6]59.3 ± 10.0
SBP, mmHg110.0 ± 10.6103.7 ± 12.0[3,4,5,6]105.2 ± 10.7[3,4,5,6]108.1 ± 9.4[4,5,6]112.6 ± 9.2[5,6]114.9 ± 9.4117.0 ± 7.9
DBP, mmHg69.2 ± 7.365.6 ± 8.3[3,4,5,6]66.7 ± 7.2[3,4,5,6]67.9 ± 6.6[4,5,6]70.6 ± 6.8671.8 ± 6.973.3 ± 5.9
Weight, kg49.8 ± 14.831.2 ± 6.6[2,3,4,5,6]37.1 ± 8.2[3,4,5,6]44.6 ± 9.5[4,5,6]55.1 ± 10.5[5,6]65.3 ± 9.6[6]69.6 ± 8.9
Height, cm156.9 ± 15.9132.8 ± 5.8 [2,3,4,5,6]140.9 ± 7.0[3,4,5,6]151.6 ± 8.4[4,5,6]165.2 ± 8.9[5,6]173.9 ± 7.5[6]177.9 ± 6.1
BMI, kg/m219.7 ± 3.117.6 ± 3.0[2,3,4,5,6]18.5 ± 3.1[3,4,5,6]19.3 ± 3.0[4,5,6]20.1 ± 2.6[5,6]21.5 ± 2.522.0 ± 2.3
BSA, (m2)1.47 ± 0.291.07 ± 0.12[2,3,4,5,6]1.20 ± 0.14[3,4,5,6]1.37 ± 0.17[4,5,6]1.60 ± 0.18[5,6]1.78 ± 0.15[6]1.86 ± 0.13
Training, h/week7.3 ± 1.26.3 ± 0.8[3,4,5,6]6.3 ± 0.7[3,4,5,6]7.0 ± 1.2[4,5,6]8.1 ± 0.78.1 ± 0.88.2 ± 0.9
Duration of training, months29.7 ± 12.712.3 ± 1.6[2,3,4,5,6]14.5 ± 8.6[3,4,5,6]28.4 ± 12.2[4,5,6]32.7 ± 16.1[5,6]41.4 ± 6.0[6]64.3 ± 5.7
Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
HR, beats/min68.8 ± 12.881.2 ± 13.2[2,3,4,5,6]74.2 ± 12.4[3,4,5,6]70.4 ± 11.3[4,5,6]66.0 ± 11.3[5,6]62.4 ± 11.1[6]59.3 ± 10.0
SBP, mmHg110.0 ± 10.6103.7 ± 12.0[3,4,5,6]105.2 ± 10.7[3,4,5,6]108.1 ± 9.4[4,5,6]112.6 ± 9.2[5,6]114.9 ± 9.4117.0 ± 7.9
DBP, mmHg69.2 ± 7.365.6 ± 8.3[3,4,5,6]66.7 ± 7.2[3,4,5,6]67.9 ± 6.6[4,5,6]70.6 ± 6.8671.8 ± 6.973.3 ± 5.9
Weight, kg49.8 ± 14.831.2 ± 6.6[2,3,4,5,6]37.1 ± 8.2[3,4,5,6]44.6 ± 9.5[4,5,6]55.1 ± 10.5[5,6]65.3 ± 9.6[6]69.6 ± 8.9
Height, cm156.9 ± 15.9132.8 ± 5.8 [2,3,4,5,6]140.9 ± 7.0[3,4,5,6]151.6 ± 8.4[4,5,6]165.2 ± 8.9[5,6]173.9 ± 7.5[6]177.9 ± 6.1
BMI, kg/m219.7 ± 3.117.6 ± 3.0[2,3,4,5,6]18.5 ± 3.1[3,4,5,6]19.3 ± 3.0[4,5,6]20.1 ± 2.6[5,6]21.5 ± 2.522.0 ± 2.3
BSA, (m2)1.47 ± 0.291.07 ± 0.12[2,3,4,5,6]1.20 ± 0.14[3,4,5,6]1.37 ± 0.17[4,5,6]1.60 ± 0.18[5,6]1.78 ± 0.15[6]1.86 ± 0.13
Training, h/week7.3 ± 1.26.3 ± 0.8[3,4,5,6]6.3 ± 0.7[3,4,5,6]7.0 ± 1.2[4,5,6]8.1 ± 0.78.1 ± 0.88.2 ± 0.9
Duration of training, months29.7 ± 12.712.3 ± 1.6[2,3,4,5,6]14.5 ± 8.6[3,4,5,6]28.4 ± 12.2[4,5,6]32.7 ± 16.1[5,6]41.4 ± 6.0[6]64.3 ± 5.7

Data expressed as mean ± SD or as absolute count (% of total).

p < 0.05 current group versus Group J, pairwise comparisons with Bonferroni adjustment for multiple comparisons.

HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; BSA: body surface area.

Table 2.

Echocardiographic measurements.

Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
LVEDD, mm46.1 ± 4.9 (25.0,58.0)40.4 ± 3.3 (25.0,48.0)[2,3,4,5,6]42.4 ± 3.3 (32.0,54.0)[3,4,5,6]44.6 ± 3.6 (33.0,55.0)[4,5,6]48.0 ± 3.9 (36.0,58.0)[5,6]50.6 ± 3.4 (37.0,58.0)51.2 ± 3.7 (35.0,58.0)
LVESD, mm27.5 ± 4.0 (15.0,37.0)23.7 ± 3.0 (16.0,32.0)[2,3,4,5,6]25.1 ± 3.1 (16.0,34.0[3,4,5,6]26.6 ± 3.3 (19.0,36.0)[4,5,6]28.6 ± 3.7 (15.0,37.0[5,6]30.4 ± 3.2 (19.0,37.0)30.9 ± 3.6 (22.0,37.0)
LVM, g106.1 ± 32.7 (35.4,234.3)69.5 ± 15.3 (37.6,118.2)[2,3,4,5,6]80.5 ± 17.4 (35.4,142.9) [3,4,5,6]94.1 ± 21.6 (41.1,199.3)[4,5,6]119.0 ± 27.8 (55.9,234.3)[5,6]137.0 ± 24.7 (44.8,213.9)142.7 ± 26.9 (51.3,205.5)
AoR, mm26.2 ± 3.4 (15.0,40.0)22.8 ± 2.0 (17.0,29.0)[2,3,4,5,6]23.8 ± 2.7 (15.0,37.0) [3,4,5,6]25.3 ± 2.7 (17.0,35.0)[4,5,6]27.2 ± 2.9 (17.0,37.0)[5,6]28.9 ± 2.9 (20.0,38.5)29.8 ± 2.6 (23.0,40.0)
LAD, mm27.7 ± 4.2 (14.0,39.0)24.5 ± 3.3 (16.0,32.0)[2,3,4,5,6]25.6 ± 3.7 (16.0,39.0) [3,4,5,6]27.3 ± 3.7 (16.0,39.0)[4,5,6]28.8 ± 4.0 (14.0,38.0)[5]29.9 ± 3.7 (19.0,39.0)29.7 ± 4.4 (19.0,39.0)
IVS, mm7.2 ± 1.2 (4.0,11.0)6.3 ± 1.0 (4.0,10.0)[2,3,4,5,6]6.6 ± 1.0 (4.0,9.0)[3,4,5,6]7.0 ± 1.1 (4.0,10.0)[4,5,6]7.5 ± 1.1 (5.0,11.0)[5,6]7.9 ± 1.1 (5.0,11.0)8.1 ± 0.9 (5.0,10.0)
LVPW, mm7.2 ± 1.1 (4.0,11.0)6.2 ± 0.8 (4.0,9.0)[2,3,4,5,6]6.6 ± 0.9 (4.0,9.0)[3,4,5,6]6.9 ± 0.9 (4.0,11.0)[4,5,6]7.5 ± 1.0 (5.0,11.0)[5,6]7.9 ± 0.8 (5.0,11.0)7.9 ± 0.8 (6.0,10.0)
FS, %21.2 ± 3.0 (7.2,29.7)21.7 ± 3.1 (9.7,27.9)21.4 ± 3.2 (7.2,29.3)21.2 ± 3.2 (11.2,29.7)21.1 ± 3.0 (8.8,29.1)21.0 ± 2.8 (12.6,29.7)20.8 ± 2.8 (12.6,26.7)
Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
LVEDD, mm46.1 ± 4.9 (25.0,58.0)40.4 ± 3.3 (25.0,48.0)[2,3,4,5,6]42.4 ± 3.3 (32.0,54.0)[3,4,5,6]44.6 ± 3.6 (33.0,55.0)[4,5,6]48.0 ± 3.9 (36.0,58.0)[5,6]50.6 ± 3.4 (37.0,58.0)51.2 ± 3.7 (35.0,58.0)
LVESD, mm27.5 ± 4.0 (15.0,37.0)23.7 ± 3.0 (16.0,32.0)[2,3,4,5,6]25.1 ± 3.1 (16.0,34.0[3,4,5,6]26.6 ± 3.3 (19.0,36.0)[4,5,6]28.6 ± 3.7 (15.0,37.0[5,6]30.4 ± 3.2 (19.0,37.0)30.9 ± 3.6 (22.0,37.0)
LVM, g106.1 ± 32.7 (35.4,234.3)69.5 ± 15.3 (37.6,118.2)[2,3,4,5,6]80.5 ± 17.4 (35.4,142.9) [3,4,5,6]94.1 ± 21.6 (41.1,199.3)[4,5,6]119.0 ± 27.8 (55.9,234.3)[5,6]137.0 ± 24.7 (44.8,213.9)142.7 ± 26.9 (51.3,205.5)
AoR, mm26.2 ± 3.4 (15.0,40.0)22.8 ± 2.0 (17.0,29.0)[2,3,4,5,6]23.8 ± 2.7 (15.0,37.0) [3,4,5,6]25.3 ± 2.7 (17.0,35.0)[4,5,6]27.2 ± 2.9 (17.0,37.0)[5,6]28.9 ± 2.9 (20.0,38.5)29.8 ± 2.6 (23.0,40.0)
LAD, mm27.7 ± 4.2 (14.0,39.0)24.5 ± 3.3 (16.0,32.0)[2,3,4,5,6]25.6 ± 3.7 (16.0,39.0) [3,4,5,6]27.3 ± 3.7 (16.0,39.0)[4,5,6]28.8 ± 4.0 (14.0,38.0)[5]29.9 ± 3.7 (19.0,39.0)29.7 ± 4.4 (19.0,39.0)
IVS, mm7.2 ± 1.2 (4.0,11.0)6.3 ± 1.0 (4.0,10.0)[2,3,4,5,6]6.6 ± 1.0 (4.0,9.0)[3,4,5,6]7.0 ± 1.1 (4.0,10.0)[4,5,6]7.5 ± 1.1 (5.0,11.0)[5,6]7.9 ± 1.1 (5.0,11.0)8.1 ± 0.9 (5.0,10.0)
LVPW, mm7.2 ± 1.1 (4.0,11.0)6.2 ± 0.8 (4.0,9.0)[2,3,4,5,6]6.6 ± 0.9 (4.0,9.0)[3,4,5,6]6.9 ± 0.9 (4.0,11.0)[4,5,6]7.5 ± 1.0 (5.0,11.0)[5,6]7.9 ± 0.8 (5.0,11.0)7.9 ± 0.8 (6.0,10.0)
FS, %21.2 ± 3.0 (7.2,29.7)21.7 ± 3.1 (9.7,27.9)21.4 ± 3.2 (7.2,29.3)21.2 ± 3.2 (11.2,29.7)21.1 ± 3.0 (8.8,29.1)21.0 ± 2.8 (12.6,29.7)20.8 ± 2.8 (12.6,26.7)

Data expressed as mean ± SD or as absolute count (% of total).

p < 0.05 current group versus Group, pairwise comparisons with Bonferroni adjustment for multiple comparisons.

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVM: left ventricular mass; AoR: aortic root; LAD: left atrial diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; FS: fractional shortening.

Table 2.

Echocardiographic measurements.

Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
LVEDD, mm46.1 ± 4.9 (25.0,58.0)40.4 ± 3.3 (25.0,48.0)[2,3,4,5,6]42.4 ± 3.3 (32.0,54.0)[3,4,5,6]44.6 ± 3.6 (33.0,55.0)[4,5,6]48.0 ± 3.9 (36.0,58.0)[5,6]50.6 ± 3.4 (37.0,58.0)51.2 ± 3.7 (35.0,58.0)
LVESD, mm27.5 ± 4.0 (15.0,37.0)23.7 ± 3.0 (16.0,32.0)[2,3,4,5,6]25.1 ± 3.1 (16.0,34.0[3,4,5,6]26.6 ± 3.3 (19.0,36.0)[4,5,6]28.6 ± 3.7 (15.0,37.0[5,6]30.4 ± 3.2 (19.0,37.0)30.9 ± 3.6 (22.0,37.0)
LVM, g106.1 ± 32.7 (35.4,234.3)69.5 ± 15.3 (37.6,118.2)[2,3,4,5,6]80.5 ± 17.4 (35.4,142.9) [3,4,5,6]94.1 ± 21.6 (41.1,199.3)[4,5,6]119.0 ± 27.8 (55.9,234.3)[5,6]137.0 ± 24.7 (44.8,213.9)142.7 ± 26.9 (51.3,205.5)
AoR, mm26.2 ± 3.4 (15.0,40.0)22.8 ± 2.0 (17.0,29.0)[2,3,4,5,6]23.8 ± 2.7 (15.0,37.0) [3,4,5,6]25.3 ± 2.7 (17.0,35.0)[4,5,6]27.2 ± 2.9 (17.0,37.0)[5,6]28.9 ± 2.9 (20.0,38.5)29.8 ± 2.6 (23.0,40.0)
LAD, mm27.7 ± 4.2 (14.0,39.0)24.5 ± 3.3 (16.0,32.0)[2,3,4,5,6]25.6 ± 3.7 (16.0,39.0) [3,4,5,6]27.3 ± 3.7 (16.0,39.0)[4,5,6]28.8 ± 4.0 (14.0,38.0)[5]29.9 ± 3.7 (19.0,39.0)29.7 ± 4.4 (19.0,39.0)
IVS, mm7.2 ± 1.2 (4.0,11.0)6.3 ± 1.0 (4.0,10.0)[2,3,4,5,6]6.6 ± 1.0 (4.0,9.0)[3,4,5,6]7.0 ± 1.1 (4.0,10.0)[4,5,6]7.5 ± 1.1 (5.0,11.0)[5,6]7.9 ± 1.1 (5.0,11.0)8.1 ± 0.9 (5.0,10.0)
LVPW, mm7.2 ± 1.1 (4.0,11.0)6.2 ± 0.8 (4.0,9.0)[2,3,4,5,6]6.6 ± 0.9 (4.0,9.0)[3,4,5,6]6.9 ± 0.9 (4.0,11.0)[4,5,6]7.5 ± 1.0 (5.0,11.0)[5,6]7.9 ± 0.8 (5.0,11.0)7.9 ± 0.8 (6.0,10.0)
FS, %21.2 ± 3.0 (7.2,29.7)21.7 ± 3.1 (9.7,27.9)21.4 ± 3.2 (7.2,29.3)21.2 ± 3.2 (11.2,29.7)21.1 ± 3.0 (8.8,29.1)21.0 ± 2.8 (12.6,29.7)20.8 ± 2.8 (12.6,26.7)
Age, years n (%)Overall 2151 (100)Group 1: 7–8 141 (7)Group 2: 9–10 448 (21)Group 3: 11–12 524 (24)Group 4: 13–14 546 (25)Group 5: 15–16 383 (18)Group 6: 17–18 109 (5)
LVEDD, mm46.1 ± 4.9 (25.0,58.0)40.4 ± 3.3 (25.0,48.0)[2,3,4,5,6]42.4 ± 3.3 (32.0,54.0)[3,4,5,6]44.6 ± 3.6 (33.0,55.0)[4,5,6]48.0 ± 3.9 (36.0,58.0)[5,6]50.6 ± 3.4 (37.0,58.0)51.2 ± 3.7 (35.0,58.0)
LVESD, mm27.5 ± 4.0 (15.0,37.0)23.7 ± 3.0 (16.0,32.0)[2,3,4,5,6]25.1 ± 3.1 (16.0,34.0[3,4,5,6]26.6 ± 3.3 (19.0,36.0)[4,5,6]28.6 ± 3.7 (15.0,37.0[5,6]30.4 ± 3.2 (19.0,37.0)30.9 ± 3.6 (22.0,37.0)
LVM, g106.1 ± 32.7 (35.4,234.3)69.5 ± 15.3 (37.6,118.2)[2,3,4,5,6]80.5 ± 17.4 (35.4,142.9) [3,4,5,6]94.1 ± 21.6 (41.1,199.3)[4,5,6]119.0 ± 27.8 (55.9,234.3)[5,6]137.0 ± 24.7 (44.8,213.9)142.7 ± 26.9 (51.3,205.5)
AoR, mm26.2 ± 3.4 (15.0,40.0)22.8 ± 2.0 (17.0,29.0)[2,3,4,5,6]23.8 ± 2.7 (15.0,37.0) [3,4,5,6]25.3 ± 2.7 (17.0,35.0)[4,5,6]27.2 ± 2.9 (17.0,37.0)[5,6]28.9 ± 2.9 (20.0,38.5)29.8 ± 2.6 (23.0,40.0)
LAD, mm27.7 ± 4.2 (14.0,39.0)24.5 ± 3.3 (16.0,32.0)[2,3,4,5,6]25.6 ± 3.7 (16.0,39.0) [3,4,5,6]27.3 ± 3.7 (16.0,39.0)[4,5,6]28.8 ± 4.0 (14.0,38.0)[5]29.9 ± 3.7 (19.0,39.0)29.7 ± 4.4 (19.0,39.0)
IVS, mm7.2 ± 1.2 (4.0,11.0)6.3 ± 1.0 (4.0,10.0)[2,3,4,5,6]6.6 ± 1.0 (4.0,9.0)[3,4,5,6]7.0 ± 1.1 (4.0,10.0)[4,5,6]7.5 ± 1.1 (5.0,11.0)[5,6]7.9 ± 1.1 (5.0,11.0)8.1 ± 0.9 (5.0,10.0)
LVPW, mm7.2 ± 1.1 (4.0,11.0)6.2 ± 0.8 (4.0,9.0)[2,3,4,5,6]6.6 ± 0.9 (4.0,9.0)[3,4,5,6]6.9 ± 0.9 (4.0,11.0)[4,5,6]7.5 ± 1.0 (5.0,11.0)[5,6]7.9 ± 0.8 (5.0,11.0)7.9 ± 0.8 (6.0,10.0)
FS, %21.2 ± 3.0 (7.2,29.7)21.7 ± 3.1 (9.7,27.9)21.4 ± 3.2 (7.2,29.3)21.2 ± 3.2 (11.2,29.7)21.1 ± 3.0 (8.8,29.1)21.0 ± 2.8 (12.6,29.7)20.8 ± 2.8 (12.6,26.7)

Data expressed as mean ± SD or as absolute count (% of total).

p < 0.05 current group versus Group, pairwise comparisons with Bonferroni adjustment for multiple comparisons.

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVM: left ventricular mass; AoR: aortic root; LAD: left atrial diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; FS: fractional shortening.

Echocardiographic measurements expressed as mean ± SD and expressed in quartiles and age ranges.
Figure 1.

Echocardiographic measurements expressed as mean ± SD and expressed in quartiles and age ranges.

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Relationship between anthropometric and echocardiographic data

Table 3 provides the results of the univariate analysis between echocardiographic measurements and the anthropometric/demographic variables, separately for raw data (top) and after log-transforming both the dependent and independent variables. The allometric approach slightly improved the variance explained by the models. BSA displayed a better association with cardiac measurements, more so than height or weight and particularly BMI, while training was not significantly associated with any of the dependent variables. Fractional shortening was not associated with any of the anthropometric measurements, and only a weak inverse relation with age was found, comparable to the existing literature.12

Table 3.

Pearson correlation coefficient r between echocardiographic and demographic or anthropometric measurements.

AgeWeightHeightBMIBSATraining
LVEDD0.68 (0.66,0.71)0.74 (0.72,0.76)0.76 (0.74,0.78)0.45 (0.42,0.49)0.77 (0.75,0.79)−0.02 (−0.06,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.6 (0.57,0.63)0.37 (0.33,0.41)0.61 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.45 (0.42,0.49)0.53 (0.49,0.56)0.50 (0.46,0.53)0.38 (0.35,0.43)0.53 (0.50,0.56)−0.04 (−0.08,0.01)
LVPW0.51 (0.48,0.54)0.60 (0.57,0.63)0.56 (0.53,0.59)0.45 (0.41,0.48)0.60 (0.57,0.63)−0.04 (−0.08,0)
AoR0.60 (0.57,0.62)0.66 (0.64,0.68)0.67 (0.64,0.69)0.42 (0.39,0.46)0.68 (0.66,0.7)−0.02 (−0.06,0.03)
LAD0.42 (0.38,0.45)0.52 (0.49,0.55)0.46 (0.43,0.5)0.42 (0.39,0.46)0.51 (0.48,0.55)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.09 (−0.13,−0.05)−0.06 (−0.1,−0.02)−0.1 (−0.14,−0.06)−0.08 (−0.12,−0.04)0.03 (−0.01,0.07)
LVM0.71 (0.68,0.73)0.79 (0.77,0.81)0.78 (0.76,0.79)0.53 (0.49,0.56)0.81 (0.79,0.82)−0.03 (−0.08,0.01)

lnAge
lnWeight
lnHeight
lnBMI
lnBSA
lnTraining
LVEDD0.68 (0.66,0.70)0.74 (0.71,0.76)0.76 (0.74,0.78)0.47 (0.43,0.50)0.76 (0.74,0.78)−0.02 (−0.07,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.60 (0.57,0.62)0.38 (0.35,0.42)0.60 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.46 (0.43,0.49)0.53 (0.50,0.56)0.50 (0.47,0.53)0.40 (0.36,0.44)0.53 (0.5,0.56)−0.04 (−0.08,0)
LVPW0.53 (0.49,0.56)0.61 (0.58,0.64)0.57 (0.54,0.60)0.46 (0.43,0.50)0.61 (0.58,0.64)−0.04 (−0.09,0)
AoR0.6 (0.58,0.63)0.66 (0.64,0.69)0.67 (0.65,0.69)0.44 (0.40,0.47)0.68 (0.66,0.71)−0.02 (−0.06,0.03)
LAD0.41 (0.37,0.45)0.51 (0.48,0.54)0.46 (0.42,0.49)0.42 (0.38,0.45)0.50 (0.47,0.54)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.06 (−0.11,−0.02)−0.09 (−0.13,−0.05)−0.10 (−0.15,−0.06)−0.08 (−0.13,−0.04)0.03 (−0.01,0.08)
LVM0.72 (0.69,0.74)0.80 (0.78,0.81)0.79 (0.77,0.81)0.55 (0.52,0.58)0.82 (0.80,0.83)−0.04 (−0.08,0.01)
AgeWeightHeightBMIBSATraining
LVEDD0.68 (0.66,0.71)0.74 (0.72,0.76)0.76 (0.74,0.78)0.45 (0.42,0.49)0.77 (0.75,0.79)−0.02 (−0.06,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.6 (0.57,0.63)0.37 (0.33,0.41)0.61 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.45 (0.42,0.49)0.53 (0.49,0.56)0.50 (0.46,0.53)0.38 (0.35,0.43)0.53 (0.50,0.56)−0.04 (−0.08,0.01)
LVPW0.51 (0.48,0.54)0.60 (0.57,0.63)0.56 (0.53,0.59)0.45 (0.41,0.48)0.60 (0.57,0.63)−0.04 (−0.08,0)
AoR0.60 (0.57,0.62)0.66 (0.64,0.68)0.67 (0.64,0.69)0.42 (0.39,0.46)0.68 (0.66,0.7)−0.02 (−0.06,0.03)
LAD0.42 (0.38,0.45)0.52 (0.49,0.55)0.46 (0.43,0.5)0.42 (0.39,0.46)0.51 (0.48,0.55)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.09 (−0.13,−0.05)−0.06 (−0.1,−0.02)−0.1 (−0.14,−0.06)−0.08 (−0.12,−0.04)0.03 (−0.01,0.07)
LVM0.71 (0.68,0.73)0.79 (0.77,0.81)0.78 (0.76,0.79)0.53 (0.49,0.56)0.81 (0.79,0.82)−0.03 (−0.08,0.01)

lnAge
lnWeight
lnHeight
lnBMI
lnBSA
lnTraining
LVEDD0.68 (0.66,0.70)0.74 (0.71,0.76)0.76 (0.74,0.78)0.47 (0.43,0.50)0.76 (0.74,0.78)−0.02 (−0.07,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.60 (0.57,0.62)0.38 (0.35,0.42)0.60 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.46 (0.43,0.49)0.53 (0.50,0.56)0.50 (0.47,0.53)0.40 (0.36,0.44)0.53 (0.5,0.56)−0.04 (−0.08,0)
LVPW0.53 (0.49,0.56)0.61 (0.58,0.64)0.57 (0.54,0.60)0.46 (0.43,0.50)0.61 (0.58,0.64)−0.04 (−0.09,0)
AoR0.6 (0.58,0.63)0.66 (0.64,0.69)0.67 (0.65,0.69)0.44 (0.40,0.47)0.68 (0.66,0.71)−0.02 (−0.06,0.03)
LAD0.41 (0.37,0.45)0.51 (0.48,0.54)0.46 (0.42,0.49)0.42 (0.38,0.45)0.50 (0.47,0.54)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.06 (−0.11,−0.02)−0.09 (−0.13,−0.05)−0.10 (−0.15,−0.06)−0.08 (−0.13,−0.04)0.03 (−0.01,0.08)
LVM0.72 (0.69,0.74)0.80 (0.78,0.81)0.79 (0.77,0.81)0.55 (0.52,0.58)0.82 (0.80,0.83)−0.04 (−0.08,0.01)

BMI: body mass index; BSA: body surface area; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Table 3.

Pearson correlation coefficient r between echocardiographic and demographic or anthropometric measurements.

AgeWeightHeightBMIBSATraining
LVEDD0.68 (0.66,0.71)0.74 (0.72,0.76)0.76 (0.74,0.78)0.45 (0.42,0.49)0.77 (0.75,0.79)−0.02 (−0.06,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.6 (0.57,0.63)0.37 (0.33,0.41)0.61 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.45 (0.42,0.49)0.53 (0.49,0.56)0.50 (0.46,0.53)0.38 (0.35,0.43)0.53 (0.50,0.56)−0.04 (−0.08,0.01)
LVPW0.51 (0.48,0.54)0.60 (0.57,0.63)0.56 (0.53,0.59)0.45 (0.41,0.48)0.60 (0.57,0.63)−0.04 (−0.08,0)
AoR0.60 (0.57,0.62)0.66 (0.64,0.68)0.67 (0.64,0.69)0.42 (0.39,0.46)0.68 (0.66,0.7)−0.02 (−0.06,0.03)
LAD0.42 (0.38,0.45)0.52 (0.49,0.55)0.46 (0.43,0.5)0.42 (0.39,0.46)0.51 (0.48,0.55)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.09 (−0.13,−0.05)−0.06 (−0.1,−0.02)−0.1 (−0.14,−0.06)−0.08 (−0.12,−0.04)0.03 (−0.01,0.07)
LVM0.71 (0.68,0.73)0.79 (0.77,0.81)0.78 (0.76,0.79)0.53 (0.49,0.56)0.81 (0.79,0.82)−0.03 (−0.08,0.01)

lnAge
lnWeight
lnHeight
lnBMI
lnBSA
lnTraining
LVEDD0.68 (0.66,0.70)0.74 (0.71,0.76)0.76 (0.74,0.78)0.47 (0.43,0.50)0.76 (0.74,0.78)−0.02 (−0.07,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.60 (0.57,0.62)0.38 (0.35,0.42)0.60 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.46 (0.43,0.49)0.53 (0.50,0.56)0.50 (0.47,0.53)0.40 (0.36,0.44)0.53 (0.5,0.56)−0.04 (−0.08,0)
LVPW0.53 (0.49,0.56)0.61 (0.58,0.64)0.57 (0.54,0.60)0.46 (0.43,0.50)0.61 (0.58,0.64)−0.04 (−0.09,0)
AoR0.6 (0.58,0.63)0.66 (0.64,0.69)0.67 (0.65,0.69)0.44 (0.40,0.47)0.68 (0.66,0.71)−0.02 (−0.06,0.03)
LAD0.41 (0.37,0.45)0.51 (0.48,0.54)0.46 (0.42,0.49)0.42 (0.38,0.45)0.50 (0.47,0.54)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.06 (−0.11,−0.02)−0.09 (−0.13,−0.05)−0.10 (−0.15,−0.06)−0.08 (−0.13,−0.04)0.03 (−0.01,0.08)
LVM0.72 (0.69,0.74)0.80 (0.78,0.81)0.79 (0.77,0.81)0.55 (0.52,0.58)0.82 (0.80,0.83)−0.04 (−0.08,0.01)
AgeWeightHeightBMIBSATraining
LVEDD0.68 (0.66,0.71)0.74 (0.72,0.76)0.76 (0.74,0.78)0.45 (0.42,0.49)0.77 (0.75,0.79)−0.02 (−0.06,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.6 (0.57,0.63)0.37 (0.33,0.41)0.61 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.45 (0.42,0.49)0.53 (0.49,0.56)0.50 (0.46,0.53)0.38 (0.35,0.43)0.53 (0.50,0.56)−0.04 (−0.08,0.01)
LVPW0.51 (0.48,0.54)0.60 (0.57,0.63)0.56 (0.53,0.59)0.45 (0.41,0.48)0.60 (0.57,0.63)−0.04 (−0.08,0)
AoR0.60 (0.57,0.62)0.66 (0.64,0.68)0.67 (0.64,0.69)0.42 (0.39,0.46)0.68 (0.66,0.7)−0.02 (−0.06,0.03)
LAD0.42 (0.38,0.45)0.52 (0.49,0.55)0.46 (0.43,0.5)0.42 (0.39,0.46)0.51 (0.48,0.55)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.09 (−0.13,−0.05)−0.06 (−0.1,−0.02)−0.1 (−0.14,−0.06)−0.08 (−0.12,−0.04)0.03 (−0.01,0.07)
LVM0.71 (0.68,0.73)0.79 (0.77,0.81)0.78 (0.76,0.79)0.53 (0.49,0.56)0.81 (0.79,0.82)−0.03 (−0.08,0.01)

lnAge
lnWeight
lnHeight
lnBMI
lnBSA
lnTraining
LVEDD0.68 (0.66,0.70)0.74 (0.71,0.76)0.76 (0.74,0.78)0.47 (0.43,0.50)0.76 (0.74,0.78)−0.02 (−0.07,0.02)
LVESD0.54 (0.51,0.57)0.59 (0.56,0.61)0.60 (0.57,0.62)0.38 (0.35,0.42)0.60 (0.58,0.63)−0.03 (−0.07,0.01)
IVS0.46 (0.43,0.49)0.53 (0.50,0.56)0.50 (0.47,0.53)0.40 (0.36,0.44)0.53 (0.5,0.56)−0.04 (−0.08,0)
LVPW0.53 (0.49,0.56)0.61 (0.58,0.64)0.57 (0.54,0.60)0.46 (0.43,0.50)0.61 (0.58,0.64)−0.04 (−0.09,0)
AoR0.6 (0.58,0.63)0.66 (0.64,0.69)0.67 (0.65,0.69)0.44 (0.40,0.47)0.68 (0.66,0.71)−0.02 (−0.06,0.03)
LAD0.41 (0.37,0.45)0.51 (0.48,0.54)0.46 (0.42,0.49)0.42 (0.38,0.45)0.50 (0.47,0.54)−0.01 (−0.05,0.03)
FS−0.06 (−0.1,−0.02)−0.06 (−0.11,−0.02)−0.09 (−0.13,−0.05)−0.10 (−0.15,−0.06)−0.08 (−0.13,−0.04)0.03 (−0.01,0.08)
LVM0.72 (0.69,0.74)0.80 (0.78,0.81)0.79 (0.77,0.81)0.55 (0.52,0.58)0.82 (0.80,0.83)−0.04 (−0.08,0.01)

BMI: body mass index; BSA: body surface area; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Allometric models, obtained using BSA and age, are described in Table 3. Model fitting was good particularly for LVEDD, LVESD, AoR and LVM (explained variance ranging from 37% to 67%), with a positive association between the echocardiographic measurements and both BSA and age. Weaker associations were found for ventricular wall thickness (IVS and LVPW) and LA diameter (LAD), but only with BSA and not age. The allometric model was not capable of describing the variance observed within the fractional shortening measures.

Normative equations and Z-scores

Normative equations on the basis of model coefficients for allometric scaling are described in the footnote to Table 4. The upper limits of echocardiographic measurements as a function of BSA and age are shown in Figure 2. For IVS, LVPW, LAD and fractional shortening the upper limits curves are independent of age, consistently with the results in Table 2.

Table 4.

Multiple linear regression analysis of echocardiographic measurements with age and BSA as independent variables, after log–log transformation.

LVEDD
LVESD
IVS
LVPW
β (95% CI)r2β (95% CI)r2β (95% CI)r2β (95% CI)r2
Constant3.52a (3.47,3.58)0.592.98a (2.89,3.07)0.371.73a (1.62,1.85)0.291.73a (1.63,1.82)0.37
Age0.07a (0.04,0.09)0.07a (0.03,0.12)0.03 (−0.02,0.08)0.03 (−0.01,0.07)
BSA0.35a (0.32,0.38)0.38a (0.33,0.42)0.43a (0.37,0.48)0.43a (0.38,0.47)
AoR
LADFSLVM

β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
Constant2.95a (2.87,3.03)0.473.24a (3.14,3.35)0.253.01a (2.89,3.13)0.003.82a (3.67,3.96)0.67
Age0.07a (0.03,0.1)−0.03 (−0.08,0.02)0.02 (−0.03,0.08)0.15a (0.09,0.22)
BSA0.39a (0.35,0.43)0.42a (0.37,0.47)−0.07a (−0.13,−0.01)1.14a (1.07,1.21)
LVEDD
LVESD
IVS
LVPW
β (95% CI)r2β (95% CI)r2β (95% CI)r2β (95% CI)r2
Constant3.52a (3.47,3.58)0.592.98a (2.89,3.07)0.371.73a (1.62,1.85)0.291.73a (1.63,1.82)0.37
Age0.07a (0.04,0.09)0.07a (0.03,0.12)0.03 (−0.02,0.08)0.03 (−0.01,0.07)
BSA0.35a (0.32,0.38)0.38a (0.33,0.42)0.43a (0.37,0.48)0.43a (0.38,0.47)
AoR
LADFSLVM

β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
Constant2.95a (2.87,3.03)0.473.24a (3.14,3.35)0.253.01a (2.89,3.13)0.003.82a (3.67,3.96)0.67
Age0.07a (0.03,0.1)−0.03 (−0.08,0.02)0.02 (−0.03,0.08)0.15a (0.09,0.22)
BSA0.39a (0.35,0.43)0.42a (0.37,0.47)−0.07a (−0.13,−0.01)1.14a (1.07,1.21)

Data are expressed as model coefficient (β) with 95% CI and Pearson correlation coefficient (r2). Index measures can be obtained by applying the following formula: indexed measure = absolute measure/(constant * ageβage * BSAβBSA).

a

Significant at the 0.05 level.

LVESD: left ventricular end-systolic diameter; LVEDD: left ventricular end-diastolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; CI: confidence interval; BSA: body surface area; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Table 4.

Multiple linear regression analysis of echocardiographic measurements with age and BSA as independent variables, after log–log transformation.

LVEDD
LVESD
IVS
LVPW
β (95% CI)r2β (95% CI)r2β (95% CI)r2β (95% CI)r2
Constant3.52a (3.47,3.58)0.592.98a (2.89,3.07)0.371.73a (1.62,1.85)0.291.73a (1.63,1.82)0.37
Age0.07a (0.04,0.09)0.07a (0.03,0.12)0.03 (−0.02,0.08)0.03 (−0.01,0.07)
BSA0.35a (0.32,0.38)0.38a (0.33,0.42)0.43a (0.37,0.48)0.43a (0.38,0.47)
AoR
LADFSLVM

β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
Constant2.95a (2.87,3.03)0.473.24a (3.14,3.35)0.253.01a (2.89,3.13)0.003.82a (3.67,3.96)0.67
Age0.07a (0.03,0.1)−0.03 (−0.08,0.02)0.02 (−0.03,0.08)0.15a (0.09,0.22)
BSA0.39a (0.35,0.43)0.42a (0.37,0.47)−0.07a (−0.13,−0.01)1.14a (1.07,1.21)
LVEDD
LVESD
IVS
LVPW
β (95% CI)r2β (95% CI)r2β (95% CI)r2β (95% CI)r2
Constant3.52a (3.47,3.58)0.592.98a (2.89,3.07)0.371.73a (1.62,1.85)0.291.73a (1.63,1.82)0.37
Age0.07a (0.04,0.09)0.07a (0.03,0.12)0.03 (−0.02,0.08)0.03 (−0.01,0.07)
BSA0.35a (0.32,0.38)0.38a (0.33,0.42)0.43a (0.37,0.48)0.43a (0.38,0.47)
AoR
LADFSLVM

β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
β (95% CI)
r2
Constant2.95a (2.87,3.03)0.473.24a (3.14,3.35)0.253.01a (2.89,3.13)0.003.82a (3.67,3.96)0.67
Age0.07a (0.03,0.1)−0.03 (−0.08,0.02)0.02 (−0.03,0.08)0.15a (0.09,0.22)
BSA0.39a (0.35,0.43)0.42a (0.37,0.47)−0.07a (−0.13,−0.01)1.14a (1.07,1.21)

Data are expressed as model coefficient (β) with 95% CI and Pearson correlation coefficient (r2). Index measures can be obtained by applying the following formula: indexed measure = absolute measure/(constant * ageβage * BSAβBSA).

a

Significant at the 0.05 level.

LVESD: left ventricular end-systolic diameter; LVEDD: left ventricular end-diastolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; CI: confidence interval; BSA: body surface area; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Nomograms for left heart diameters and wall thickness, as a function of body surface area and age class distribution. The curved lines indicate Z-score = 2.
Figure 2.

Nomograms for left heart diameters and wall thickness, as a function of body surface area and age class distribution. The curved lines indicate Z-score = 2.

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass BSA: body surface area

Standardized Z-scores can be calculated using the equations listed in Table 5. For instance, in a 14-year-old subject, with a BSA = 1.60 and LVEDD = 56 mm, the relevant Z-score should be calculated as the difference between the measured and the expected values, normalized by the mean square error: (ln(56) – (3.52 + 0.07·ln(14) + 0.35 ln(1.60)))/0.11, resulting in Z = 1.42, which is not indicative for LV dilation (Z-score < 2). The same case is graphically shown in Figure 3. For a given BSA the upper limit of LVEDD (Z-score = 2) can be read from this nomogram and, in this case of a non-dilated LVEDD, the diameter falls under the nomogram line.

Table 5.

Equations for the calculation of Z-score given the echocardiographic measure y.

LVEDD
LVEDD, mm[ln(y) – (1.22 + 0.07·ln(Age) + 0.35 ln(BSA))]/0.11
LVESD, mm[ln(y) – (0.68 + 0.07·ln(Age) + 0.38·ln(BSA))]/0.15
IVS, mm[ln(y) – (1.73 + 0.03·ln(Age) + 0.43 ln(BSA))]/0.17
LVPW, mm[ln(y) – (1.73 + 0.03 ln(Age) + 0.43·ln(BSA))]/0.15
AoR, mm[ln(y) – (2.95 + 0.07 ln(Age) + 0.39·ln(BSA))]/0.13
LAD, mm[ln(y) – (3.24 – 0.03 ln(Age) + 0.42 ln(BSA))]/0.15
FS, %[ln(y) – (3.01 + 0.02 ln(Age) – 0.07·ln(BSA))]/0.15
LVM, g[ln(y) – (3.82 + 0.15·ln(Age) + 1.14 ln(BSA))]/0.31
LVEDD
LVEDD, mm[ln(y) – (1.22 + 0.07·ln(Age) + 0.35 ln(BSA))]/0.11
LVESD, mm[ln(y) – (0.68 + 0.07·ln(Age) + 0.38·ln(BSA))]/0.15
IVS, mm[ln(y) – (1.73 + 0.03·ln(Age) + 0.43 ln(BSA))]/0.17
LVPW, mm[ln(y) – (1.73 + 0.03 ln(Age) + 0.43·ln(BSA))]/0.15
AoR, mm[ln(y) – (2.95 + 0.07 ln(Age) + 0.39·ln(BSA))]/0.13
LAD, mm[ln(y) – (3.24 – 0.03 ln(Age) + 0.42 ln(BSA))]/0.15
FS, %[ln(y) – (3.01 + 0.02 ln(Age) – 0.07·ln(BSA))]/0.15
LVM, g[ln(y) – (3.82 + 0.15·ln(Age) + 1.14 ln(BSA))]/0.31

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Table 5.

Equations for the calculation of Z-score given the echocardiographic measure y.

LVEDD
LVEDD, mm[ln(y) – (1.22 + 0.07·ln(Age) + 0.35 ln(BSA))]/0.11
LVESD, mm[ln(y) – (0.68 + 0.07·ln(Age) + 0.38·ln(BSA))]/0.15
IVS, mm[ln(y) – (1.73 + 0.03·ln(Age) + 0.43 ln(BSA))]/0.17
LVPW, mm[ln(y) – (1.73 + 0.03 ln(Age) + 0.43·ln(BSA))]/0.15
AoR, mm[ln(y) – (2.95 + 0.07 ln(Age) + 0.39·ln(BSA))]/0.13
LAD, mm[ln(y) – (3.24 – 0.03 ln(Age) + 0.42 ln(BSA))]/0.15
FS, %[ln(y) – (3.01 + 0.02 ln(Age) – 0.07·ln(BSA))]/0.15
LVM, g[ln(y) – (3.82 + 0.15·ln(Age) + 1.14 ln(BSA))]/0.31
LVEDD
LVEDD, mm[ln(y) – (1.22 + 0.07·ln(Age) + 0.35 ln(BSA))]/0.11
LVESD, mm[ln(y) – (0.68 + 0.07·ln(Age) + 0.38·ln(BSA))]/0.15
IVS, mm[ln(y) – (1.73 + 0.03·ln(Age) + 0.43 ln(BSA))]/0.17
LVPW, mm[ln(y) – (1.73 + 0.03 ln(Age) + 0.43·ln(BSA))]/0.15
AoR, mm[ln(y) – (2.95 + 0.07 ln(Age) + 0.39·ln(BSA))]/0.13
LAD, mm[ln(y) – (3.24 – 0.03 ln(Age) + 0.42 ln(BSA))]/0.15
FS, %[ln(y) – (3.01 + 0.02 ln(Age) – 0.07·ln(BSA))]/0.15
LVM, g[ln(y) – (3.82 + 0.15·ln(Age) + 1.14 ln(BSA))]/0.31

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum; LVPW: left ventricular posterior wall; AoR: aortic root; LAD: left atrial diameter; FS: fractional shortening; LVM: left ventricular mass

Example showing how to use nomograms. For a 14-year-old child with a body surface area (BSA) of 1.6 m2, a measured LVEDD of 56 mm is not dilated (Z-score = 1.42, represented by the blue line). The red line represents Z-score = 2, upper physiological limit of normal values for age and BSA.
Figure 3.

Example showing how to use nomograms. For a 14-year-old child with a body surface area (BSA) of 1.6 m2, a measured LVEDD of 56 mm is not dilated (Z-score = 1.42, represented by the blue line). The red line represents Z-score = 2, upper physiological limit of normal values for age and BSA.

LVEDD: left ventricular end-diastolic diameter

Comparison of our allometric models with existing literature

Figure 4 depicts a qualitative comparison between the allometric models described in Table 4 and those described by Kampmann et al.15 for LV diameters, and Kaldarova et al.16 for AoR, in a similar cohort of subjects. In all cases, only BSA, and not age, was entered as an independent variable. A good agreement between the allometric models was found for both LVEDD and LVESD, with an over-estimation by the model from the literature for the youngest patients with the largest BSA, and under-estimation in older patients with reduced BSA. As far as the AoR is concerned, the association here reported with BSA was much weaker than that reported in the literature, leading to non-negligible under- and over-estimation in subjects with higher or lower BSA, respectively.

Comparison between predicted values obtained by applying to our study population the normative equations derived using two-dimensional echocardiography (red surface) and those obtained, in the same population, by applying normative equations by Kampmann et al.15 and Kaldarova et al.16 derived using two-dimensional echocardiography in a similar population of children and young adults (grey surface). Normative surfaces are shown as a function of BSA and age.
Figure 4.

Comparison between predicted values obtained by applying to our study population the normative equations derived using two-dimensional echocardiography (red surface) and those obtained, in the same population, by applying normative equations by Kampmann et al.15 and Kaldarova et al.16 derived using two-dimensional echocardiography in a similar population of children and young adults (grey surface). Normative surfaces are shown as a function of BSA and age.

LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; AoR: aortic root; BSA: body surface area

Inter-observer variability was 2.2% for LVEDD, 3.9% for LVESD, 3.9% for AoR, 5.1% for LAD, 6.5% for IVS and 3.1% for LVPW. Intra-observer variability was 1.69% for LVEDD, 2.1% for LVESD, 1.46% for AoR, 1.42% for LAD, 3.3% for IVS and 3.2% for LVPW. Importantly, both the inter- and intra-observer variability were well below 10%.

Discussion

The importance of reference values and Z-score

We have presented the reference values for a set of left heart parameters in a large population of healthy peri-pubertal athletes, and the association between this set of cardiac measurements and anthropometric variables in this unique study population. The nomograms allow determination of the Z-score ≤ 2 (≤95th percentile) as a function of age and BSA. The Z-score of a measurement is the number of standard deviations of that value from the mean value. If a measurement is equal to the population mean, the Z-score is 0; a Z-score of +2 or −2 corresponds to the 95th and the 5th percentile, respectively (i.e. two standard deviations above or below the mean).4 The main benefit of using Z-scores has been the absence of any dependence on a predetermined association between the size of a structure and BSA17 and Z-scores are particularly useful in tracking allometric growth over time.18 This new set of nomograms is helpful to sport medicine clinicians in the recognition of mild LV abnormalities and the quantification of their progression over time in athletes aged ≤18 years as Z-score = 2 is easily visually assessed. Nomograms for left heart dimensions and wall thickness are crucial for diagnostic purpose at PPS to better differentiate the normal growth and physiological adaptation to physical training from pathologic abnormalities.

Limitation of the previously proposed reference values

Based on the criticisms of the previous reference values as highlighted by Cantinotti et al.4 and Mawad et al.,5 the published normal ranges are affected by scarce consideration of confounders, such as gender, and discrepant normalization of data to account for the effects of body size and age. These limits were overcome as the reference population included a large sample size of healthy males with a 10-year age range and similar training characteristics; furthermore all echocardiographic measurements were standardized according to the ASE recommendations and Z-scores were defined. Our normative data may be useful for diagnosis at PPS and in the follow-up of athletes who fall into a grey zone between athlete’s heart and an initial cardiac abnormality.

The peri-pubertal athlete versus non-athlete population

The comparison between our population and a non-athlete population, estimated by the equation generated by previous published articles,15,16 advocated that in this age range physical training does not largely affect the size of the left ventricle, in terms of LVEDD and LVESD, as measured by 2D echocardiography. The suboptimal overlap in the normative surfaces shown in Figure 4 can be explained by the lack of anthropometric adjustments in the normative equations retrieved from the literature, leading to a large mismatch for the most extreme body size. Conversely, in the case of AoR, the discrepancy between the two models was apparent. This could have been due to the different population used to build the models, but also could be an effect of training. Specifically designed studies are needed to corroborate this hypothesis. Molecular, morphologic and functional cardiac adaptations to athletic training are known as athlete’s heart. While moderate exercise can be mostly beneficial, intense exercise induces molecular modifications that could even be detrimental and translated in a functional decline in systolic and diastolic cardiac function.19 An exaggerated reactive oxygen species production has been linked to this effect of intense training, but an inter-individual variability exists in the redox imbalance that can be counterweighted by antioxidants intake. This can be morphologically and functionally translated in an inter-individual variability of the acute right ventricle (RV) impairment evaluated by speckle-tracking echocardiography after a trail-running race, independent of prior training.20 While adult athlete’s heart has been extensively studied with different imaging modalities,21,22 the paediatric physiological adaptation to intensive training is less evident and some studies failed to identify clinical features of athlete’s heart in prepubertal subjects,23 while another reported a significant increase only in LV and LA dimensions and AoR diameter.24 Among different sports, endurance training influences the growing heart of male preadolescent athletes with an addictive increase in RV dimensions and in biatrial volumes, with a preserved RV and biatrial function, thus enforcing the hypothesis of a physiological adaptation to physical activity.25,26 Gender difference exists in athlete’s heart, with the female sex showing lower left ventricular mass and thicknesses compared with males, without geometrical differences in terms of LV remodelling.27 Despite these different reports, a recent meta-analysis28 focused on electrical and structural adaptations of the paediatric athlete’s heart, concluding that paediatric athletes had significantly greater LV diameters and thickness, LVM and LAD. Even if the age was a positive predictor of those parameters, the magnitude, prevalence and distribution of such changes are dependent on the chronological age of the paediatric athlete.28 No specific values for age class or BSA were available, nor nomograms to accurately derive Z-score values. Therefore, our LV nomograms could be used to evaluate peri-pubertal children undergoing PPS. Due to the noteworthy amount of training per week (see Table 1) and to the specific training of soccer players, caution should be applied when using these nomograms to evaluate athletes practising sports other than soccer, or female athletes or non-Caucasian athletes. Independently from the Z-score value obtained for a specific parameter, the sports physician must take care of other parameters, such as physical examination, family history and ECG findings, and evaluate whether further evaluation are required to investigate for pathologic cardiovascular disorders associated with sudden cardiac death in athletes. Furthermore, echocardiography as a diagnostic tool has limitations in sensitivity and specificity, in particular inter-observer variability among physicians remains a major concern and can hamper results. The actual innovations in imaging technology, including three-dimensional echocardiography, speckle tracking echocardiography and cardiac magnetic resonance, have enhanced the diagnostic capabilities of the current imaging modalities and made possible the correct identification of the athlete’s heart grey zone.29,30

Potential limitations

The generalizability of our results may be limited by the homogeneity of the study population with respect to sex, ethnicity and practised sports. The lack of peri-pubertal female athletes, non-Caucasian athletes and athletes practising other sports except soccer represent a relevant limitation of this study. The cardiovascular impact of soccer is a mix of high dynamic and moderate static demand. Although these findings cannot be applied in sports different from soccer, the current data can give a general idea of the degree of remodelling also in other sports.

Also, we decided to focus only on conventional parameters of the left heart that are always evaluated in a standard echocardiography; still tissue Doppler and speckle tracking imaging are promising tools in athlete’s heart evaluation, but are not universally adopted in PPS evaluation.30,31 Other authors have already published normal values of AoR diameter,32 pulse wave Doppler and tissue Doppler imaging6 in paediatric populations; however, to our knowledge no such nomograms exist in trained peri-pubertal athletes. The evaluation of the right heart will be the object of other ongoing research in a sub-group of this study population, where different RV parameters were assessed. The effect of training could only be evaluated on the basis of normative equations, obtained in large sets of peri-pubertal athletes and non-athletes, given the lack of a group of matched controls. The stage of athletes’ puberty has not been assessed by a proper scale, such as the Tanner scale, therefore the term ‘peri-pubertal’ covers subjects in a heterogeneous age range of from 8 to 18 years.

Conclusion

In this study we present reference values for left heart measurements in peri-pubertal athletes with Z-score for normalized data. We are confident that we have successfully reduced the influence of age and body surface area and this set of nomograms will ease the interpretation of 2D echocardiography for the sport medicine physician at PPS. These data should be further integrated with other important factors such as ECG data, family history, ventricular morphology and symptoms in order to clear the athlete for PPS.

Author contribution

EC, FM, LC and FP conceived the study, participated in data collection, analysis and manuscript drafting, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. FM performed the statistical analysis, participated in the manuscript drafting and revised it critically. FS, EG, AN, FQ, MM, MR and CF participated in acquisition of data, analysis, interpretation and manuscript drafting, revising it critically for key intellectual content. All authors read and approved the final version of the study. LC and FP are joint last authors.

Acknowledgements

The authors are extremely grateful to Dr Elaine Tyndall for her critical reading. This study has been approved by the local institutional review board. The authors declare that the data of the research article are original.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by unrestricted grant from Villa Stuart Sport Clinic, FIFA Medical Centre of Excellence and partially funded by Sapienza University of Rome (grant number 2016/43780) to Elena Cavarretta.

References

1

Sharma
S
,
Maron
BJ
,
Whyte
G
et al.  
Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete’s heart and hypertrophic cardiomyopathy
.
J Am Coll Cardiol
 
2002
;
40
:
1431
1436
.

2

Sharma S, Drezner JA, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J 2018; 39: 1466–1480
.

3

Migliore
F
,
Zorzi
A
,
Michieli
P
et al.  
Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening
.
Circulation
 
2012
;
125
:
529
538
.

4

Cantinotti
M
,
Scalese
M
,
Molinaro
S
et al.  
Limitations of current echocardiographic nomograms for left ventricular, valvular, and arterial dimensions in children: a critical review
.
J Am Soc Echocardiogr
 
2012
;
25
:
142
152
.

5

Mawad
W
,
Drolet
C
,
Dahdah
N
et al.  
A review and critique of the statistical methods used to generate reference values in pediatric echocardiography
.
J Am Soc Echocardiogr
 
2013
;
26
:
29
37
.

6

Dallaire
F
,
Slorach
C
,
Hui
W
et al.  
Reference values for pulse wave Doppler and tissue Doppler imaging in pediatric echocardiography
.
Circ Cardiovasc Imaging
 
2015
;
8
:
e002167
e002167
.

7

Rizzo
M
,
Spataro
A
,
Cecchetelli
C
et al.  
Structural cardiac disease diagnosed by echocardiography in asymptomatic young male soccer players: Implications for pre-participation screening
.
Br J Sports Med
 
2012
;
46
:
371
373
.

8

Calò
L
,
Sperandii
F
,
Martino
A
et al.  
Echocardiographic findings in 2261 peri-pubertal athletes with or without inverted T waves at electrocardiogram
.
Heart
 
2015
;
101
:
193
200
.

9

Dallaire
F
,
Bigras
JL
,
Prsa
M
et al.  
Bias related to body mass index in pediatric echocardiographic Z scores
.
Pediatr Cardiol
 
2015
;
36
:
667
676
.

10

World Medical Association
.
World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects
.
JAMA
 
2013
;
310
:
2191
2194
.

11

Lopez
L
,
Colan
SD
,
Frommelt
PC
et al.  
Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
.
J Am Soc Echocardiogr
 
2010
;
23
:
465
495
.

12

De Simone
G
,
Kimball
TR
,
Roman
MJ
et al.  
Relation of left ventricular chamber and midwall function to age in normal children, adolescents and adults
.
Ital Heart J
 
2000
;
1
:
295
300
.

13

Haycock
GB
,
Schwartz
GJ
,
Wisotsky
DH
.
Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adults
.
J Pediatr
 
1978
;
93
:
62
66
.

14

Sluysmans
T
,
Colan
SD
.
Theoretical and empirical derivation of cardiovascular allometric relationships in children
.
J Appl Physiol (1985)
 
2005
;
99
:
445
457
.

15

Kampmann
C
,
Wiethoff
CM
,
Wenzel
A
et al.  
Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe
.
Heart
 
2000
;
83
:
667
672
.

16

Kaldararova
M
,
Balazova
E
,
Tittel
P
et al.  
Echocardiographic measurements of the aorta in normal children and young adults
.
Bratisl Lek Listy
 
2007
;
108
:
437
441
.

17

Neilan
TG
,
Pradhan
AD
,
King
ME
et al.  
Derivation of a size-independent variable for scaling of cardiac dimensions in a normal paediatric population
.
Eur J Echocardiogr
 
2009
;
10
:
50
55
.

18

Chubb
H
,
Simpson
JM
.
The use of Z-scores in paediatric cardiology
.
Ann Pediatr Cardiol
 
2012
;
5
:
179
184
.

19

Cavarretta
E
,
Peruzzi
M
,
Frati
G
et al.  
When enough is more than enough: The hidden side of the cardiac effects of intense physical exercise
.
Int J Cardiol
 
2018
;
258
:
224
225
.

20

Sanz de la Garza
M
,
Grazioli
G
,
Bijnens
BH
et al.  
Inter-individual variability in right ventricle adaptation after an endurance race
.
Eur J Prev Cardiol
 
2016
;
23
:
1114
1124
.

21

De Castro
S
,
Pelliccia
A
,
Caselli
S
et al.  
Remodelling of the left ventricle in athlete’s heart: A three dimensional echocardiographic and magnetic resonance imaging study
.
Heart
 
2006
;
92
:
975
976
.

22

De Castro
S
,
Caselli
S
,
Maron
M
et al.  
Left ventricular remodelling index (LVRI) in various pathophysiological conditions: A real-time three-dimensional echocardiographic study
.
Heart
 
2007
;
93
:
205
209
.

23

Rowland
TW
,
Unnithan
VB
,
MacFarlane
NG
et al.  
Clinical manifestations of the ‘athlete’s heart’ in prepubertal male runners
.
Int J Sports Med
 
1994
;
15
:
515
519
.

24

Zdravkovic
M
,
Perunicic
J
,
Krotin
M
et al.  
Echocardiographic study of early left ventricular remodeling in highly trained preadolescent footballers
.
J Sci Med Sport
 
2010
;
13
:
602
606
.

25

D’Ascenzi
F
,
Pelliccia
A
,
Valentini
F
et al.  
Training-induced right ventricular remodelling in pre-adolescent endurance athletes: The athlete’s heart in children
.
Int J Cardiol
 
2017
;
236
:
270
275
.

26

D’Ascenzi
F
,
Solari
M
,
Anselmi
F
et al.  
Atrial chamber remodelling in healthy pre-adolescent athletes engaged in endurance sports: A study with a longitudinal design. The CHILD study
.
Int J Cardiol
 
2016
;
223
:
325
330
.

27

Pelà
G
,
Crocamo
A
,
Li Calzi
M
et al.  
Sex-related differences in left ventricular structure in early adolescent non-professional athletes
.
Eur J Prev Cardiol
 
2016
;
23
:
777
784
.

28

McClean
G
,
Riding
NR
,
Ardern
CL
et al.  
Electrical and structural adaptations of the paediatric athlete’s heart: A systematic review with meta-analysis
.
Br J Sports Med
 
2018
;
52
:
230
230
.

29

Pelliccia A, Caselli S, Sharma S, et al. European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: Recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete’s heart. Eur Heart J. Epub ahead of print 23 September 2017. DOI: 10.1093/eurheartj/ehx532
.

30

D’Ascenzi
F
,
Caselli
S
,
Solari
M
et al.  
Novel echocardiographic techniques for the evaluation of athletes’ heart: A focus on speckle-tracking echocardiography
.
Eur J Prev Cardiol
 
2016
;
23
:
437
446
.

31

Lotrionte
M
,
Cavarretta
E
,
Abbate
A
et al.  
Temporal changes in standard and tissue Doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer
.
Am J Cardiol
 
2013
;
112
:
1005
1012
.

32

Gautier
M
,
Detaint
D
,
Fermanian
C
et al.  
Nomograms for aortic root diameters in children using two-dimensional echocardiography
.
Am J Cardiol
 
2010
;
105
:
8888
8894
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.